Thomas W. Beetham Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

KNSA Quotes by TradingView

Thomas W. Beetham is EVP & Chief Legal Officer of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 297,523 shares of KNSA, which is worth approximately $6.85 Million. The most recent transaction as insider was on Feb 03, 2021, when has been sold 2,477 shares (Class A Common Shares) at a price of $22.09 per share, resulting in proceeds of $54,717. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 298K
0% 3M change
0% 12M change
Total Value Held $6.85 Million

Thomas W. Beetham Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 03 2021
SELL
Open market or private sale
$54,717 $22.09 p/Share
2,477 Reduced 0.83%
297,523 Class A Common Shares
Feb 03 2021
BUY
Conversion of derivative security
-
300,000 Added 50.0%
300,000 Class A Common Shares

Also insider at

MGTA
Magenta Therapeutics, Inc. Healthcare
Officer
VRDN
Viridian Therapeutics, Inc.\DE Healthcare
Chief Operating Officer
TWB

Thomas W. Beetham

EVP & Chief Legal Officer
Cambridge, MA

Track Institutional and Insider Activities on KNSA

Follow Kiniksa Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KNSA